1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with pimagedine in 10 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (pimagedine) | Trials (pimagedine) | Recent Studies (post-2010) (pimagedine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 2,162 | 18 | 390 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | pimagedine (IC50) |
|---|---|---|---|
| Nitric oxide synthase, brain | Homo sapiens (human) | 5.9 | |
| Nitric oxide synthase, inducible | Homo sapiens (human) | 4.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castellino, P; DeFronzo, RA; Tuttle, KR | 1 |
| Ali, SS; Brownlee, M; Federlin, K; Geisen, K; Hammes, HP; Uhlmann, M; Weiss, A | 1 |
| Meijer, F; Ruijter, JM; Van Delft, JL; Van Haeringen, NJ | 1 |
| Boku, Y; Fujii, T; Hongo, H; Kondo, M; Nakahashi, Y; Takano, H; Yamaguchi, T; Yamamoto, H; Yanagisawa, R; Yoshida, N; Yoshikawa, T | 1 |
| Gonzalez-Crussi, F; Hsueh, W; Qu, XW; Sun, XM; Tan, XD | 1 |
| Carvalho-Tavares, J; Fox-Robichaud, A; Kubes, P | 1 |
| Fujii, E; Irie, K; Ishida, H; Muraki, T; Wada, K; Yoshioka, T | 1 |
| Abo, M; Fujimura, M; Ishiura, Y; Myou, S; Nobata, K; Nonomura, A; Oribe, Y | 1 |
| McLarnon, JG; Ryu, JK; Tran, KC | 1 |
| Cho, KO; Choi, IW; Choi, JH; Im, SY; Kim, HA; Kim, KJ; Kim, SH; Ko, HM; Oh, SH | 1 |
10 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pimagedine
| Article | Year |
|---|---|
Diabetic nephropathy.
Topics: Adrenergic beta-Antagonists; Aldehyde Reductase; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, Protein-Restricted; Diuretics; Exercise; Glycosylation; Guanidines; Humans; Hypertension; Platelet Activating Factor; Rats; Somatostatin; Weight Loss | 1994 |
Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats.
Topics: Animals; Basement Membrane; Blood Glucose; Capillaries; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glycosylation; Guanidines; Male; Platelet Activating Factor; Rats; Rats, Wistar; Reference Values; Retina; Retinal Vessels; Time Factors | 1995 |
Nitric oxide induces vascular permeability changes in the guinea pig conjunctiva.
Topics: Albumins; Animals; Arginine; Capillary Permeability; Conjunctiva; Conjunctivitis, Allergic; Enzyme Inhibitors; Female; Guanidines; Guinea Pigs; Ketorolac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Platelet Activating Factor; Regional Blood Flow; Tolmetin; Vasodilator Agents | 1995 |
Effects of aminoguanidine on systemic inflammatory response syndrome induced by platelet activating factor and by lipopolysaccharide in rats.
Topics: Animals; Disease Models, Animal; Enzyme Induction; Enzyme Inhibitors; Guanidines; Injections, Intravenous; Lipopolysaccharides; Male; Nitrates; Nitric Oxide Synthase; Nitrites; Nitroarginine; Platelet Activating Factor; Rats; Systemic Inflammatory Response Syndrome | 1997 |
Injurious and protective mechanisms in the gut. Interaction of PAF, phospholipase A2, eicosanoids, and nitric oxide synthase.
Topics: Animals; Eicosanoids; Enzyme Activation; Enzyme Inhibitors; Group II Phospholipases A2; Guanidines; Inflammation; Intestinal Mucosa; Isothiuronium; Leukotriene C4; Male; Models, Biological; Nitric Oxide; Nitric Oxide Synthase; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Vasoconstriction | 1997 |
Assessment of the mechanism of juxtacrine activation and adhesion of leukocytes in liver microcirculation.
Topics: Animals; Cell Adhesion; Enzyme Inhibitors; Gene Expression Regulation; Guanidines; Histamine; Intercellular Adhesion Molecule-1; Kinetics; Leukocytes; Leukotriene C4; Liver Circulation; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Microcirculation; P-Selectin; Platelet Activating Factor; Venules | 1999 |
Microvascular permeability change induced by platelet-activating factor is impaired in diabetic mice.
Topics: Animals; Azo Compounds; Capillary Permeability; Coloring Agents; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Glycoconjugates; Guanidines; Hypoglycemic Agents; Indomethacin; Insulin; Male; Methylene Blue; Mice; Mice, Mutant Strains; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Platelet Activating Factor; Skin; Streptozocin; Trypan Blue | 1999 |
In vivo PAF-induced airway eosinophil accumulation reduces bronchial responsiveness to inhaled histamine.
Topics: Administration, Inhalation; Animals; Asthma; Bronchi; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Eosinophils; Guanidines; Guinea Pigs; Histamine; Male; Platelet Activating Factor | 2005 |
Induction of angiogenesis by platelet-activating factor in the rat striatum.
Topics: Animals; CD11b Antigen; Cell Count; Corpus Striatum; Diterpenes; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Ginkgolides; Glial Fibrillary Acidic Protein; Guanidines; Immunohistochemistry; Lactones; Male; Neovascularization, Physiologic; Phosphopyruvate Hydratase; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2005 |
Nitric oxide plays a key role in the platelet-activating factor-induced enhancement of resistance against systemic candidiasis.
Topics: Animals; Candida albicans; Candidiasis; Female; Guanidines; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Infiltration; Neutrophils; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Platelet Activating Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2008 |